Skip to main content
. 2008 Jul 11;7:127. doi: 10.1186/1475-2875-7-127

Table 2.

Efficacy outcomes (per protocol analysis) on days 14 and 28

Day 14 AM-L AS+AQ
ACPR 100 107
ETF 0 0
LCF 1 0
LPF 2 2

Day 28

ACPR 97 102
ETF 0 0
LCF 3 1
LPF 3 4

AM-L = artemether-lumefantrine, AS+AQ = artesunate+amodiaquine

Day 28 cure rates are cumulative figures from day 14. ACPR = adequate clinical and parasitological response, ETF = early treatment failure, LCF = late clinical failure, LPF = late parasitological failure